Atlas Trials

Evaluate the Efficacy of Faricimab in Patients With Neovascular Age-related Macular Degeneration

Clinical trial NCT07367282 · RECRUITING

Trial details

NCT number
NCT07367282
Sponsor
Junyeop Lee
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Macular Degeneration
Start date
2026-06-29
Primary completion
2028-04-30
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.